Diabetic Macular Edema – Epidemiology – Middle East and Africa

Clarivate Epidemiology’s coverage of diabetic macular edema (DME) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of DME for each country, as well as annualized case counts projected to the national population.

Clarivate Epidemiology’s DME forecast will answer the following questions:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of DME over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology forecasts five DME patient populations, as follows:

  • Total prevalent cases.
  • DME with mild nonproliferative diabetic retinopathy.
  • DME with moderate nonproliferative diabetic retinopathy.
  • DME with severe nonproliferative diabetic retinopathy.
  • DME with proliferative diabetic retinopathy.

Note: Coverage may vary by country.